InvestorsHub Logo
Followers 214
Posts 22563
Boards Moderated 2
Alias Born 05/19/2010

Re: Drugdoctor post# 117957

Saturday, 04/22/2017 5:02:45 PM

Saturday, April 22, 2017 5:02:45 PM

Post# of 119915
Agree. What shareholders here are overlooking is that BETS has crossed over from borrowing money to positive cash flow. They have no reason to take on anymore toxic debt now that they have flipped from red to green, RAPIDLY if I may say. The new s/s and this kind of revenue is going to change the pps to a very high level and very quickly as soon as they are become current and shareholders learn of their "access to funding."

"For the 4th quarter turnover revenue was in excess of $3.3 million and gross profit was in excess of $250,000 (US). We reinvested all of our gross profit into acquitting additional customers to our platform. Turnover revenue in the first quarter is projected to grow to $6.7 million. With continued access to funding we believe we can sustain this growth into the 2nd quarter."

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.